Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2014

Jul 1, 2014

35086_dirs_2014-06-30_1de883bc-39ee-4c8c-ac02-389c3644014a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2014-06-30

Reporting Person: Vivaldi Coelho Rogerio (Director, President and CEO)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $2.71 Common Stock (540722) Direct

Footnotes

F1: 25% of the shares subject to the option will become exercisable November 1, 2014, and the balance of the option shares will become exercisable in a series of twelve equal quarterly installments upon Dr. Vivaldi's completion of each quarter of service over the three year period thereafter.